Beta Bionics

Forecast & Rating13 analysts currently cover Beta Bionics, with about 69.2% giving a positive rating — meaning they expect the stock to rise. The average price target is $23.28, about 22.8% upside from the current price of $18.96. Price targets range from $16.00 to $30.40 — a wide spread, showing clear disagreement over just how much Beta Bionics can rise. Historically, about 78.8% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Beta Bionics closely still see room for the stock to rise. Data as of Sep 30, 2026; for reference only and not investment advice.